Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SHLT

SHL Telemedicine (SHLT)

SHL Telemedicine Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SHLT
DateTimeSourceHeadlineSymbolCompany
06/20/20246:32AMBusiness WireSHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli ActivityNASDAQ:SHLTSHL Telemedicine Ltd
05/21/20241:45AMBusiness WireSHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood TestNASDAQ:SHLTSHL Telemedicine Ltd
05/16/20241:45AMBusiness WireSHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft LaunchNASDAQ:SHLTSHL Telemedicine Ltd
04/17/20246:59AMIH Market NewsUS Index Futures See Gains, Oil Prices DipNASDAQ:SHLTSHL Telemedicine Ltd
04/17/20245:00AMBusiness WireSHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical MilestonesNASDAQ:SHLTSHL Telemedicine Ltd
04/11/20242:10AMBusiness WireImperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient CareNASDAQ:SHLTSHL Telemedicine Ltd
04/08/20242:30AMBusiness WireSHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 ExperimentNASDAQ:SHLTSHL Telemedicine Ltd
04/05/20242:30AMBusiness WireSHL Telemedicine: Invitation to Conference Call Presenting Annual Results 2023NASDAQ:SHLTSHL Telemedicine Ltd
03/14/20243:40PMBusiness WireSHL Telemedicine erhält eine Kaufempfehlung mit einem Kursziel von $11,00NASDAQ:SHLTSHL Telemedicine Ltd
03/14/20243:40PMBusiness WireSHL Telemedicine reçoit une recommandation d’achat avec un objectif de prix de 11,00 dollarsNASDAQ:SHLTSHL Telemedicine Ltd
03/14/202410:40AMBusiness WireSHL Telemedicine Receives Buy Rating with $11.00 Price TargetNASDAQ:SHLTSHL Telemedicine Ltd
02/14/20248:29AMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SHLTSHL Telemedicine Ltd
02/01/20242:30AMBusiness WireImperial College London TELE-ACS Clinical Trial Results, Using SHL Telemedicine’s SmartHeart® Technology, to Be Presented at ACC 24NASDAQ:SHLTSHL Telemedicine Ltd
12/28/20236:15AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SHLTSHL Telemedicine Ltd
12/26/20234:10PMEdgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:SHLTSHL Telemedicine Ltd
12/21/202312:12PMEdgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:SHLTSHL Telemedicine Ltd
12/19/20232:36AMBusiness WireSHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024NASDAQ:SHLTSHL Telemedicine Ltd
11/27/20232:00AMBusiness WireSHL Telemedicine Introduces SmartHeart® Direct-to-Consumer Membership Plan in the USNASDAQ:SHLTSHL Telemedicine Ltd
11/06/20231:48AMBusiness WireSHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth VisitsNASDAQ:SHLTSHL Telemedicine Ltd
10/23/20231:00AMBusiness WireSHL Telemedicine Announces Advancements in its Direct-to-Consumer Strategy in the USNASDAQ:SHLTSHL Telemedicine Ltd
09/26/20232:43AMBusiness WireSHL Telemedicine's SmartHeart® Technology Shows Remarkable Effects in Mayo Clinic and Imperial College London TrialsNASDAQ:SHLTSHL Telemedicine Ltd
09/21/20237:54AMBusiness WireSHL Announces Half-Year Results 2023 – Strategic Moves to Accelerate GrowthNASDAQ:SHLTSHL Telemedicine Ltd
09/11/20231:34AMBusiness WireSHL Telemedicine's SmartHeart® Technology to Take Center Stage at Upcoming VPM 2023 ConferenceNASDAQ:SHLTSHL Telemedicine Ltd
09/06/20238:00AMPR Newswire (US)SHL Telemedicine: Half-year results 2023 and Conference Call Scheduled for September 21, 2023NASDAQ:SHLTSHL Telemedicine Ltd
06/22/20234:16PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SHLTSHL Telemedicine Ltd
06/09/20234:02PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SHLTSHL Telemedicine Ltd
05/15/20234:01PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SHLTSHL Telemedicine Ltd
 Showing the most relevant articles for your search:NASDAQ:SHLT